Nye publikasjoner

Publikasjonene er basert på PubMed-søket «Department of Clinical Medicine» and «Bergen».

Nivå 2

• Clinical cut-offs for hip- and knee arthroplasty outcome – minimal clinically important improvement (MCII) and patient acceptable symptom state (PASS) of patient-reported outcome measures (PROM).
  Paulsen A, Djuv A, Dalen I.
  Qual Life Res. 2025 Jan 20. 
• Change in Lumbar Lordosis After Decompressive Surgery in Lumbar Spinal Stenosis Patients and Associations With Patient-Related Outcomes Two Years After Surgery: Radiologic and Clinical Results From the NORDSTEN Spinal Stenosis Trial.
  Åkerstedt J, Wänman J, Banitalebi H, Myklebust TÅ, Weber C, Storheim K, Hellum C, Indrekvam K, Hermansen E, Brisby H.
  Spine (Phila Pa 1976). 2025 Jan 20.
• Exploring dental students’ knowledge on oral cancer prevention: a cross-sectional study in Moldova, Armenia, and Belarus.
  Golburean O, Uncuta D, Manrikyan G, Shakavets N, Vardanyan I, Markaryan M, Özkaya F, Costea DE, Osman TA.
  BMC Oral Health. 2025 Jan 16;25(1):81.
• Low maternal iodine intake and subsequent risk of pharmacologically treated hypertension: A population-based prospective cohort study.
  Wikerholmen MB, Rosendahl-Riise H, Børresen KØ, Haugsgjerd TR, Gerdts E, Brantsæter AL.
  Clin Nutr. 2025 Jan 7;45:148-155.
• Clinical and Genetic Characteristics of Congenital Hyperinsulinism in Norway: A Nationwide Cohort Study.
  Velde CD, Molnes J, Berland S, Njølstad PR, Molven A.
  J Clin Endocrinol Metab. 2025 Jan 21;110(2):554-563. 

Nivå 1

• Speech therapy for exercise-induced laryngeal obstruction.
  Vreim K, Karlsen T, Carlsen PH, Nistad VH, Røksund OD, Halvorsen T, Vollsæter M, Heimdal JH, Clemm H, Engan M.
  Eur Arch Otorhinolaryngol. 2025 Jan 21. 
• Lifetime progression of IgA nephropathy: a retrospective cohort study with extended long-term follow-up.
  Rivedal M, Nordbø OP, Haaskjold YL, Bjørneklett R, Knoop T, Eikrem Ø.
  BMC Nephrol. 2025 Jan 21;26(1):32. 
• Impaired folate status in patients with mental disorders.
  Rajen N, Velure HW, Johnsen E, Bjørke-Monsen AL.
  Acta Neuropsychiatr. 2025 Jan 20:1-17. 
• Choroidal thickness and vascular density after rhegmatogenous retinal detachment.
  Skeiseid L, Thomseth VM, Achour H, Forsaa VA.
  Acta Ophthalmol. 2025 Jan 18.
• Breaking boundaries: A rare case of glioblastoma with uncommon extraneural metastases: A case report and literature review.
  Taule EM, Brekke J, Miletic H, Sætran H, Maric S, HogenEsch I, Mahesparan R.
  Brain Spine. 2024 Oct 10;4:103927.
• Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder – recommendations from ECTRIMS and the EBMT.
  Muraro PA, Mariottini A, Greco R, Burman J, Iacobaeus E, Inglese M, Snowden JA, Alexander T, Amato MP, Bø L, Boffa G, Ciccarelli O, Cohen JA, Derfuss T, Farge D, Freedman MS, Gaughan M, Heesen C, Kazmi M, Kirzigov K, Ljungman P, Mancardi G, Martin R, Mehra V, Moiola L, Saccardi R, Tintoré M, Stankoff B, Sharrack B; Attendees of the ECTRIMS Focused Workshop on HSCT.
  Nat Rev Neurol. 2025 Jan 15.
• Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy.
  Honoré A, Gravdal K, Juliebø-Jones P, Reisæter LAR, Beisland C, Moen CA.
  BJUI Compass. 2025 Jan 14;6(1):e486.
• Clinical derivation and data simulated validation of rule-out and rule-in algorithms for the Siemens Atellica IM high-sensitivity cardiac troponin I assay.
  Restan IZ, Steiro OT, Pickering JW, Tjora HL, Langørgen J, Omland T, Collinson P, Bjørneklett R, Vikenes K, Steinsvik T, Skadberg Ø, Mjelva ØR, Larsen AI, Bonarjee VVS, Aakre KM.
  Eur Heart J Acute Cardiovasc Care. 2025 Jan 28:zuaf017. 
• A multi-country cohort database study to assess pregnancy and infant outcomes after potential maternal or paternal exposure to cladribine tablets in the treatment of multiple sclerosis: the CLEAR study methods and status update.
  Hellwig K, Magyari M, MacDonald TM, Cesta CE, Wergeland S, Leinonen MK, Ornoy A, Vukusic S, Lauer A, Zhou X, Kawai A, Weinrib R, Arana A, Boumenna T.
  Ther Adv Neurol Disord. 2025 Jan 27;18:17562864241310996. 
• RADAR-AD: assessment of multiple remote monitoring technologies for early detection of Alzheimer’s disease.
  Lentzen M, Vairavan S, Muurling M, Alepopoulos V, Atreya A, Boada M, de Boer C, Conde P, Curcic J, Frisoni G, Galluzzi S, Gjestsen MT, Gkioka M, Grammatikopoulou M, Hausner L, Hinds C, Lazarou I, de Mendonça A, Nikolopoulos S, Religa D, Scebba G, Jelle Visser P, Wittenberg G, Narayan VA, Coello N, Brem AK, Aarsland D, Fröhlich H; RADAR-AD.
  Alzheimers Res Ther. 2025 Jan 27;17(1):29. 
• Repurposing neuroleptics: clozapine as a novel, adjuvant therapy for melanoma brain metastases.
  Wikerholmen T, Taule EM, Rigg E, Berle BF, Sættem M, Sarnow K, Saed HS, Sundstrøm T, Thorsen F.
  Clin Exp Metastasis. 2025 Jan 25;42(2):12. 
• ASO Visual Abstract: Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair-Modelling Oncological Outcomes and Numbers Needed to Treat.
  Kanani A, Veen T, Lea D, Zaharia C, Watson M, Alexeeva M, Thorsen K, Søreide K.
  Ann Surg Oncol. 2025 Jan 23. 
• MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer.
  Wagner-Larsen KS, Lura N, Gulati A, Ryste S, Hodneland E, Fasmer KE, Woie K, Bertelsen BI, Salvesen Ø, Halle MK, Smit N, Krakstad C, Haldorsen IS.
  BMC Cancer. 2025 Jan 22;25(1):122.
• Sex Differences in the Prognostic Value of Circulating Biomarkers in Patients Presenting With Acute Chest Pain.
  Myrmel GMS, Saeed N, Steiro OT, Tjora HL, Langørgen J, Bjørneklett RO, Skadberg Ø, Bonarjee VVS, Mjelva ØR, Pedersen ER, Vikenes K, Omland T, Aakre KM.
  JACC Adv. 2025 Jan 21;4(2):101567. 
• Increased expression of CXCL10 and CCL3 salivary gland chemokines in primary Sjögren’s syndrome detected and systematically quantified using RNAscope®in situ hybridization.
  Borge H, Ringstad IB, Aqrawi LA, Fromreide S, Dongre HN, Galtung HK, Jensen JL, Skarstein K.
  Clin Exp Immunol. 2025 Jan 21;219(1):uxae087. 
• Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3).
  Puco K, Notland CS, Szulkin R, Jonasson C, Beisland C, Johannesen TB, Solli O, Oldenburg J, Heinrich D.
  Cancer Manag Res. 2025 Jan 22;17:103-112.